Transcriptomics Market by Type (Instruments, Consumables, Software, Services), Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), Application (Diagnostics and Disease Profiling, Drug Discovery, and

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,499	145 Pages	IMARC Services Pvt. Ltd.	January, 2023	IMRC17678244

Best Price Guarantee
Price	from $2,499
Length	145 Pages
Publisher	IMARC Services Pvt. Ltd.
Published Date	January, 2023
SKU	IMRC17678244

Transcriptomics Market by Type (Instruments, Consumables, Software, Services), Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), Application (Diagnostics and Disease Profiling, Drug Discovery, and Others), End User (Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Others), and Region 2023-2028

The global transcriptomics market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.54 Billion by 2028, exhibiting a growth rate (CAGR) of 6.60% during 2023-2028.

Transcriptomics is the analysis of the ribonucleic acid (RNA) transcripts produced by the genotype of any organism at a specific time, condition, or cell. It links the genome, the proteome, and the cellular phenotype. Transcriptomics encompasses everything relating to RNAs, including their transcription and expression levels, functions, locations, trafficking, and degradation. Transcriptomics utilizes microarray analysis, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies to determine the transcriptional structure of genes. It also assists researchers in characterizing transcriptional activity, focuses on a subset of relevant target genes and transcripts, and identifies genes and pathways that respond to and counteract biotic and abiotic environmental stresses.

Transcriptomics Market Trends:
The increasing demand for personalized medicine across the globe is creating a positive outlook for the market. Transcriptomics is widely used due to the rising number of PCR applications and the improvements in the field, such as the widespread usage of RNA sequencing. In line with this, the rising demand for RNA sequencing in research applications to obtain genetic information is also favoring the market growth. RNA sequencing has completely transformed transcriptome analysis, enabling the quantification of gene expression levels in a single study and the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. Apart from this, key players are constantly focusing on developing novel instruments and techniques in diseases and diagnosis, which, in turn, is augmenting the market growth. Additionally, the launch of an advanced gene profiling product with whole transcriptome sequencing (WTS) that can provide detailed RNA sequencing analysis is positively influencing the market growth. Besides this, extensive research and development (R&D) activities, increasing demand for transcriptomics due to the outbreak of the Covid-19 disease, and the implementation of various government initiatives and funding for omics are supporting the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global transcriptomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, application and end user.

Breakup by Type:

Instruments
Consumables
Software
Services

Breakup by Technology:

Microarray
Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
Sequencing Technologies

Breakup by Application:

Diagnostics and Disease Profiling
Drug Discovery
Others

Breakup by End User:

Academic and Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc., Biospyder Technologies Inc., Illumina Inc., Nanostring Technologies Inc., Qiagen, Roche Holding AG, Takara Bio Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report
1. What was the size of the global transcriptomics market in 2022?
2. What is the expected growth rate of the global transcriptomics market during 2023-2028?
3. What are the key factors driving the global transcriptomics market?
4. What has been the impact of COVID-19 on the global transcriptomics market?
5. What is the breakup of the global transcriptomics market based on type?
6. What is the breakup of the global transcriptomics market based on the technology?
7. What is the breakup of the global transcriptomics market based on the application?
8. What are the key regions in the global transcriptomics market?
9. Who are the key players/companies in the global transcriptomics market?

1 Preface
2 Scope and Methodology: 2.1 Objectives of the Study; 2.2 Stakeholders; 2.3 Data Sources; 2.3.1 Primary Sources; 2.3.2 Secondary Sources; 2.4 Market Estimation; 2.4.1 Bottom-Up Approach; 2.4.2 Top-Down Approach; 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction: 4.1 Overview; 4.2 Key Industry Trends
5 Global Transcriptomics Market: 5.1 Market Overview; 5.2 Market Performance; 5.3 Impact of COVID-19; 5.4 Market Forecast
6 Market Breakup by Type: 6.1 Instruments; 6.1.1 Market Trends; 6.1.2 Market Forecast; 6.2 Consumables; 6.2.1 Market Trends; 6.2.2 Market Forecast; 6.3 Software; 6.3.1 Market Trends; 6.3.2 Market Forecast; 6.4 Services; 6.4.1 Market Trends; 6.4.2 Market Forecast
7 Market Breakup by Technology: 7.1 Microarray; 7.1.1 Market Trends; 7.1.2 Market Forecast; 7.2 Real-Time Quantitative Polymerase Chain Reaction (Q-PCR); 7.2.1 Market Trends; 7.2.2 Market Forecast; 7.3 Sequencing Technologies; 7.3.1 Market Trends; 7.3.2 Market Forecast
8 Market Breakup by Application: 8.1 Diagnostics and Disease Profiling; 8.1.1 Market Trends; 8.1.2 Market Forecast; 8.2 Drug Discovery; 8.2.1 Market Trends; 8.2.2 Market Forecast; 8.3 Others; 8.3.1 Market Trends; 8.3.2 Market Forecast
9 Market Breakup by End User: 9.1 Academic and Research Institutes; 9.1.1 Market Trends; 9.1.2 Market Forecast; 9.2 Pharmaceutical Companies; 9.2.1 Market Trends; 9.2.2 Market Forecast; 9.3 Biotechnology Companies; 9.3.1 Market Trends; 9.3.2 Market Forecast; 9.4 Others; 9.4.1 Market Trends; 9.4.2 Market Forecast
10 Market Breakup by Region: 10.1 North America; 10.1.1 United States; 10.1.1.1 Market Trends; 10.1.1.2 Market Forecast; 10.1.2 Canada; 10.1.2.1 Market Trends; 10.1.2.2 Market Forecast; 10.2 Asia-Pacific; 10.2.1 China; 10.2.1.1 Market Trends; 10.2.1.2 Market Forecast; 10.2.2 Japan; 10.2.2.1 Market Trends; 10.2.2.2 Market Forecast; 10.2.3 India; 10.2.3.1 Market Trends; 10.2.3.2 Market Forecast; 10.2.4 South Korea; 10.2.4.1 Market Trends; 10.2.4.2 Market Forecast; 10.2.5 Australia; 10.2.5.1 Market Trends; 10.2.5.2 Market Forecast; 10.2.6 Indonesia; 10.2.6.1 Market Trends; 10.2.6.2 Market Forecast; 10.2.7 Others; 10.2.7.1 Market Trends; 10.2.7.2 Market Forecast; 10.3 Europe; 10.3.1 Germany; 10.3.1.1 Market Trends; 10.3.1.2 Market Forecast; 10.3.2 France; 10.3.2.1 Market Trends; 10.3.2.2 Market Forecast; 10.3.3 United Kingdom; 10.3.3.1 Market Trends; 10.3.3.2 Market Forecast; 10.3.4 Italy; 10.3.4.1 Market Trends; 10.3.4.2 Market Forecast; 10.3.5 Spain; 10.3.5.1 Market Trends; 10.3.5.2 Market Forecast; 10.3.6 Russia; 10.3.6.1 Market Trends; 10.3.6.2 Market Forecast; 10.3.7 Others; 10.3.7.1 Market Trends; 10.3.7.2 Market Forecast; 10.4 Latin America; 10.4.1 Brazil; 10.4.1.1 Market Trends; 10.4.1.2 Market Forecast; 10.4.2 Mexico; 10.4.2.1 Market Trends; 10.4.2.2 Market Forecast; 10.4.3 Others; 10.4.3.1 Market Trends; 10.4.3.2 Market Forecast; 10.5 Middle East and Africa; 10.5.1 Market Trends; 10.5.2 Market Breakup by Country; 10.5.3 Market Forecast
11 SWOT Analysis: 11.1 Overview; 11.2 Strengths; 11.3 Weaknesses; 11.4 Opportunities; 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis: 13.1 Overview; 13.2 Bargaining Power of Buyers; 13.3 Bargaining Power of Suppliers; 13.4 Degree of Competition; 13.5 Threat of New Entrants; 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape: 15.1 Market Structure; 15.2 Key Players; 15.3 Profiles of Key Players; 15.3.1 Agilent Technologies Inc.; 15.3.1.1 Company Overview; 15.3.1.2 Product Portfolio; 15.3.1.3 Financials; 15.3.1.4 SWOT Analysis; 15.3.2 Becton Dickinson and Company; 15.3.2.1 Company Overview; 15.3.2.2 Product Portfolio; 15.3.2.3 Financials; 15.3.2.4 SWOT Analysis; 15.3.3 BGI Group; 15.3.3.1 Company Overview; 15.3.3.2 Product Portfolio; 15.3.3.3 Financials; 15.3.4 Bio-Rad Laboratories Inc.; 15.3.4.1 Company Overview; 15.3.4.2 Product Portfolio; 15.3.4.3 Financials; 15.3.4.4 SWOT Analysis; 15.3.5 Biospyder Technologies Inc.; 15.3.5.1 Company Overview; 15.3.5.2 Product Portfolio; 15.3.6 Illumina Inc.; 15.3.6.1 Company Overview; 15.3.6.2 Product Portfolio; 15.3.6.3 Financials; 15.3.6.4 SWOT Analysis; 15.3.7 Nanostring Technologies Inc.; 15.3.7.1 Company Overview; 15.3.7.2 Product Portfolio; 15.3.7.3 Financials; 15.3.8 Qiagen; 15.3.8.1 Company Overview; 15.3.8.2 Product Portfolio; 15.3.8.3 Financials; 15.3.8.4 SWOT Analysis; 15.3.9 Roche Holding AG; 15.3.9.1 Company Overview; 15.3.9.2 Product Portfolio; 15.3.9.3 Financials; 15.3.10 Takara Bio Inc.; 15.3.10.1 Company Overview; 15.3.10.2 Product Portfolio; 15.3.10.3 Financials; 15.3.11 Thermo Fisher Scientific Inc.; 15.3.11.1 Company Overview; 15.3.11.2 Product Portfolio; 15.3.11.3 Financials; 15.3.11.4 SWOT Analysis; Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

Transcriptomics Market Size, Trends, Analysis, and Outlook By Technology (Microarray, Real-time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), By Product (Consumables, Instruments, Others), By Application (Diagnostics and Disease Profiling, Drug Discovery, Others), by Region, Country, Segment, and Companies, 2024-2030

March, 2024 | Published by: VPA Research | USD $3,980
Transcriptomics Market Report by Type (Instruments, Consumables, Software, Services), Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), Application (Diagnostics and Disease Profiling, Drug Discovery, and Others), End User (Academic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Others), and Region 2024-2032

March, 2024 | Published by: IMARC Services Pvt. Ltd. | USD $3,899
Global Real-time Polymerase Chain Reaction (PCR) Machines Market Growth 2024-2030

February, 2024 | Published by: LP Information, Inc. | USD $3,660
Polymerase Chain Reaction Market by Product (Consumables & Reagents, Instruments, Software & Services), Technology (Digital PCR, Real-time PCR, Traditional PCR), Application, End-User - Global Forecast 2024-2030

January, 2024 | Published by: 360iResearch | USD $4,749
Transcriptomics Technologies Market, By Technology (Microarrays, PCR, Gene Regulation Technologies, Next Generation Sequencing), By Application (Clinical Diagnostics, Drug Discovery & Research, Bioinformatics, Comparative Transcriptomics), and By Region (

May, 2022 | Published by: Coherent Market Insights | USD $4,500
Polymerase Chain Reaction (PCR) Consumables Market, By Product (PCR Tubes, PCR Microplates, Cap/Lids), Technology (Real Time, Digital, Traditional), Application (Research, Clinical), End-use (Hospital, Diagnostic Labs, CROs) – Global Forecast (2024 – 2032)

May, 2024 | Published by: Global Market Insights | USD $4,850

PDF E-mail From Publisher:	$2,499
Five User License Fulfilled by Publisher:	$3,499
Global Site License Fulfilled by Publisher:	$4,499

Transcriptomics Market by Type (Instruments, Consumables, Software, Services), Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), Application (Diagnostics and Disease Profiling, Drug Discovery, and

Research Assistance

Other tasks

Transcriptomics Market by Type (Instruments, Consumables, Software, Services), Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction (Q-PCR), Sequencing Technologies), Application (Diagnostics and Disease Profiling, Drug Discovery, and

Global Real-time Polymerase Chain Reaction (PCR) Machines Market Growth 2024-2030

Polymerase Chain Reaction Market by Product (Consumables & Reagents, Instruments, Software & Services), Technology (Digital PCR, Real-time PCR, Traditional PCR), Application, End-User - Global Forecast 2024-2030

Transcriptomics Technologies Market, By Technology (Microarrays, PCR, Gene Regulation Technologies, Next Generation Sequencing), By Application (Clinical Diagnostics, Drug Discovery & Research, Bioinformatics, Comparative Transcriptomics), and By Region (

Polymerase Chain Reaction (PCR) Consumables Market, By Product (PCR Tubes, PCR Microplates, Cap/Lids), Technology (Real Time, Digital, Traditional), Application (Research, Clinical), End-use (Hospital, Diagnostic Labs, CROs) – Global Forecast (2024 – 2032)

Research Assistance

Other tasks